Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertrophic Cardiomyopathy: New Concepts and Therapies
Barry J. Maron, Ethan J. Rowin, Martin S. Maron
Annual Review of Medicine (2022) Vol. 73, Iss. 1, pp. 363-375
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The Role of Stem Cells in the Treatment of Cardiovascular Diseases
Estera Bakinowska, Kajetan Kiełbowski, Dominika Boboryko, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3901-3901
Open Access | Times Cited: 11
Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy
Ping Yang, Yingmei Lou, Zilong Geng, et al.
Circulation (2024) Vol. 150, Iss. 4, pp. 283-298
Open Access | Times Cited: 6
Deficiency of Transcription Factor Sp1 Contributes to Hypertrophic Cardiomyopathy
Fulei Zhang, Huixing Zhou, Jinfeng Xue, et al.
Circulation Research (2024) Vol. 134, Iss. 3, pp. 290-306
Open Access | Times Cited: 5
Cardiac tissue engineering: an emerging approach to the treatment of heart failure
Hossein Rayat Pisheh, Fatemeh Sadat Nojabaei, Ahmad Darvishi, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 5
Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)
Lazar Velicki, Dejana Popović, Nduka C. Okwose, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1361-1368
Open Access | Times Cited: 4
The Impact of Disopyramide on Exercise Capacity Among Patients with Obstructive Hypertrophic Cardiomyopathy: Beyond LVOT Gradient
Géza Halász, L Dei, Francesco Moroni, et al.
European Journal of Preventive Cardiology (2024)
Closed Access | Times Cited: 4
Exploring Health‐Related Quality of Life in Children With Hypertrophic Cardiomyopathy and Relationship to Physical Activity
Mitchell J. Wagner, Aamir Jeewa, Tara Pidborochynski, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
The molecular and cellular landscape of hypertrophic cardiomyopathy phenotypes: transition from obstructive to end-stage heart failure
Jude Taylor, Sean Lal, Filip Braet, et al.
Journal of Molecular Medicine (2025)
Closed Access
Modifiable Health Behaviours in Children with HCM: Lessons from the Heart Health Survey
Mitchell J. Wagner, Aamir Jeewa, Tara Pidborochynski, et al.
Pediatric Cardiology (2025)
Closed Access
The hypertrophic cardiomyopathy-associated A331P actin variant enhances basal contractile activity and elicits resting muscle dysfunction
Matthew Doran, Michael J. Rynkiewicz, Evan A. Despond, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111816-111816
Open Access
Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population
Ruilin Liu, Yifeng Yang, Ke Wei Gong, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Mendelian Randomization Study on the Associations Between Genetically Predicted Cardiovascular Disease Subtypes and the Risk of Developing Cardiomyopathies
Qiaolin Tang, Xiangzhu Meng, Xiaowen Tu, et al.
Clinical and Applied Thrombosis/Hemostasis (2025) Vol. 31
Open Access
KLK8: charting new territories in left ventricular hypertrophy biomarker research
Buqing Cao, Wenhong Yu, Zhihong Diao, et al.
Biomarkers in Medicine (2025), pp. 1-10
Closed Access
Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination
Lingfeng Zhong, Shanshan Dai, Fan Yu, et al.
Advanced Science (2025)
Open Access
Identification of biomarkers associated with energy metabolism in hypertrophic cardiomyopathy and exploration of potential mechanisms of roles
Songyan Cai, Tong Jin, M Liu, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Predictors of sudden cardiac death in post-myectomy hypertrophic cardiomyopathy with obstruction
Changsheng Zhu, Shujuan Yang, Kankan Zhao, et al.
Heart Rhythm (2025)
Closed Access
The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy
Luca Pugliese, Alessandra Luciano, Marcello Chiocchi
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 5, pp. 189-189
Open Access
Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis
Zixi Huang, Konglan Lin, Jiaxing Huang, et al.
International Journal of Cardiology (2024) Vol. 409, pp. 132213-132213
Closed Access | Times Cited: 3
A deep learning platform to assess drug proarrhythmia risk
Ricardo Serrano, Dries Feyen, Arne A.N. Bruyneel, et al.
Cell stem cell (2022) Vol. 30, Iss. 1, pp. 86-95.e4
Open Access | Times Cited: 13
Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy
Zhuang Tian, Fang Wang, Wei Jin, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e071473-e071473
Open Access | Times Cited: 7
Diretriz de Tomografia Computadorizada e Ressonância Magnética Cardiovascular da Sociedade Brasileira de Cardiologia e do Colégio Brasileiro de Radiologia – 2024
Tiago Augusto Magalhães, Adriano Camargo de Castro Carneiro, Valéria de Melo Moreira, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 2
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology – 2024
Tiago Augusto Magalhães, Adriano Camargo de Castro Carneiro, Valéria de Melo Moreira, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 2
Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
Xifeng Zheng, Bin Yang, Hui Hao-sheng, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Hypertrophic Cardiomyopathy: Current Treatment and Future Options
Sneha Annie Sebastian, Venkatesh Panthangi, Karanbir Singh, et al.
Current Problems in Cardiology (2022) Vol. 48, Iss. 4, pp. 101552-101552
Closed Access | Times Cited: 11
Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation
Patrick Erñst, Philip A. Bidwell, Michaela Dora, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top